These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29312258)

  • 21. Genomic Study of a
    Isidro J; Menezes J; Serrano M; Borges V; Paixão P; Mimoso M; Martins F; Toscano C; Santos A; Henriques AO; Oleastro M
    Front Microbiol; 2018; 9():2994. PubMed ID: 30574133
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial susceptibility of clostridium difficile clinical isolates in iran.
    Goudarzi M; Goudarzi H; Alebouyeh M; Azimi Rad M; Shayegan Mehr FS; Zali MR; Aslani MM
    Iran Red Crescent Med J; 2013 Aug; 15(8):704-11. PubMed ID: 24578839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CdtR Regulates TcdA and TcdB Production in Clostridium difficile.
    Lyon SA; Hutton ML; Rood JI; Cheung JK; Lyras D
    PLoS Pathog; 2016 Jul; 12(7):e1005758. PubMed ID: 27414650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
    Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Prevalence of Multidrug-Resistant
    Mutai WC; Mureithi MW; Anzala O; Revathi G; Kullin B; Burugu M; Kyany'a C; Odoyo E; Otieno P; Musila L
    Front Cell Infect Microbiol; 2020; 10():604986. PubMed ID: 33628744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China.
    Wang R; Suo L; Chen HX; Song LJ; Shen YY; Luo YP
    Int J Infect Dis; 2018 Feb; 67():86-91. PubMed ID: 28736259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of
    Mihajlov K; Andreska A; Ristovska N; Grdanoska T; Trajkovska-Dokic E
    Open Access Maced J Med Sci; 2019 Jun; 7(12):1896-1899. PubMed ID: 31406525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.
    Pituch H; Brazier JS; Obuch-Woszczatyński P; Wultańska D; Meisel-Mikołajczyk F; Łuczak M
    J Med Microbiol; 2006 Feb; 55(Pt 2):207-213. PubMed ID: 16434714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
    Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.
    Gerber M; Walch C; Löffler B; Tischendorf K; Reischl U; Ackermann G
    J Med Microbiol; 2008 Jun; 57(Pt 6):776-783. PubMed ID: 18480337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B.
    Eckert C; Emirian A; Le Monnier A; Cathala L; De Montclos H; Goret J; Berger P; Petit A; De Chevigny A; Jean-Pierre H; Nebbad B; Camiade S; Meckenstock R; Lalande V; Marchandin H; Barbut F
    New Microbes New Infect; 2015 Jan; 3():12-7. PubMed ID: 25755885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of binary-toxin genes (
    Azimirad M; Naderi Noukabadi F; Lahmi F; Yadegar A
    Gastroenterol Hepatol Bed Bench; 2018; 11(Suppl 1):59-65. PubMed ID: 30809324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
    Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
    Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of Toxigenic Clostridium difficile from Animal Manure and Composts Being Used as Biological Soil Amendments.
    Dharmasena M; Jiang X
    Appl Environ Microbiol; 2018 Aug; 84(16):. PubMed ID: 29858208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
    Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
    Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027.
    McGovern AM; Androga GO; Knight DR; Watson MW; Elliott B; Foster NF; Chang BJ; Riley TV
    PLoS One; 2017; 12(11):e0187658. PubMed ID: 29117204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficilein vitro.
    Aldape MJ; Packham AE; Heeney DD; Rice SN; Bryant AE; Stevens DL
    J Med Microbiol; 2017 Oct; 66(10):1393-1399. PubMed ID: 28893366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile causing pediatric infections: New findings from a hospital-based study in Italy.
    Spigaglia P; Barbanti F; Castagnola E; Diana MC; Pescetto L; Bandettini R
    Anaerobe; 2017 Dec; 48():262-268. PubMed ID: 29066337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-acquired infection with hypervirulent
    Muñoz M; Camargo M; Ríos-Chaparro DI; Gómez P; Patarroyo MA; Ramírez JD
    Gut Pathog; 2017; 9():63. PubMed ID: 29151897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.